Localized Therapy

Turn Therapeutics Reports GX-03 Skin Inflammation Research

Westlake Village, California, August 20, 2026 Turn Therapeutics announced new peer-reviewed research providing in-vivo evidence that GX-03 selectively reduces...

By cGxPwire Editor
August 21, 2026

Bio-Pharma

Valion Bio Advances Entolimod for Radiation Emergencies

SAN ANTONIO, Texas, May 19, 2026 Valion Bio, Inc. has announced a high-level joint engagement with senior officials from...

By cGxPwire Editor
May 21, 2026

.Clinical

Continuity Biosciences Launches Pancreatic Cancer Trial

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...

By cGxPwire Editor
May 21, 2026

.Tech Bio-Pharma

Privo Technologies Completes Phase 2 Run-In for PRV111 Oral Cancer Patch

PEABODY, Mass., Oct. 14, 2025 — Privo Technologies, Inc., a clinical-stage biopharmaceutical company pioneering localized cancer therapies, announced the...